IRulya Therapeutics Inc 10-Q for FY2022 Q2
IRulya Therapeutics Inc. (IRLA)
10-Q
2022-08-09
For: 2022-06-30
View Original
Added on
April 05, 2026
About this 10-Q
IRulya Therapeutics Inc filed this 10-Q on August 9, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $16.56M
- compared with a net loss of $21.75M a year earlier
- Diluted EPS
- -$0.51
- compared with -$0.74 a year earlier